0001593968-21-002517.txt : 20211202 0001593968-21-002517.hdr.sgml : 20211202 20211202172116 ACCESSION NUMBER: 0001593968-21-002517 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211201 FILED AS OF DATE: 20211202 DATE AS OF CHANGE: 20211202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pande Atul CENTRAL INDEX KEY: 0001643071 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38958 FILM NUMBER: 211467833 MAIL ADDRESS: STREET 1: C/O AXOVANT SCIENCES, INC. STREET 2: 1441 BROADWAY, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karuna Therapeutics, Inc. CENTRAL INDEX KEY: 0001771917 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270605902 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 HIGH STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-449-2244 MAIL ADDRESS: STREET 1: 99 HIGH STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2021-12-01 0001771917 Karuna Therapeutics, Inc. KRTX 0001643071 Pande Atul C/O KARUNA THERAPEUTICS, INC. 99 HIGH STREET, 26TH FLOOR BOSTON MA 02110 true false false false Common Stock 2021-12-01 4 M false 2500 16 A 2500 D Common Stock 2021-12-01 4 S false 2500 127.73 D 0 D Option (right to buy) 16 2021-12-01 4 M false 2500 0 D 2020-06-15 2029-06-26 Common Stock 2500 5000 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2021. /s/ Troy Ignelzi, Attorney-in-Fact 2021-12-02